140 related articles for article (PubMed ID: 8824249)
21. Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells.
Jakowlew SB; Mariano JM; You L
Growth Factors; 1997; 14(2-3):177-97. PubMed ID: 9255608
[TBL] [Abstract][Full Text] [Related]
22. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.
Sawdey M; Podor TJ; Loskutoff DJ
J Biol Chem; 1989 Jun; 264(18):10396-401. PubMed ID: 2499579
[TBL] [Abstract][Full Text] [Related]
23. Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system.
Medcalf RL
J Biol Chem; 1992 Jun; 267(17):12220-6. PubMed ID: 1318313
[TBL] [Abstract][Full Text] [Related]
24. Positive and negative regulation of a tumor necrosis factor response in melanoma cells.
Johnson SE; Baglioni C
J Biol Chem; 1990 Apr; 265(12):6642-9. PubMed ID: 2324095
[TBL] [Abstract][Full Text] [Related]
25. Role of c-Jun and proximal phorbol 12-myristate-13-acetate-(PMA)-responsive elements in the regulation of basal and PMA-stimulated plasminogen-activator inhibitor-1 gene expression in HepG2.
Arts J; Grimbergen J; Bosma PJ; Rahmsdorf HJ; Kooistra T
Eur J Biochem; 1996 Oct; 241(2):393-402. PubMed ID: 8917435
[TBL] [Abstract][Full Text] [Related]
26. Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells.
Mayer M; Lund LR; Riccio A; Skouv J; Nielsen LS; Stacey SN; Danø K; Andreasen PA
J Biol Chem; 1988 Oct; 263(30):15688-93. PubMed ID: 3262618
[TBL] [Abstract][Full Text] [Related]
27. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.
Shetty S; Kumar A; Idell S
Mol Cell Biol; 1997 Mar; 17(3):1075-83. PubMed ID: 9032234
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of the tissue-type plasminogen-activator gene in human endothelial cells: identification of nuclear factors that recognise functional elements in the tissue-type plasminogen-activator gene promoter.
Costa M; Shen Y; Maurer F; Medcalf RL
Eur J Biochem; 1998 Nov; 258(1):123-31. PubMed ID: 9851700
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol ester.
Lund LR; Eriksen J; Ralfkiaer E; Rømer J
J Invest Dermatol; 1996 Apr; 106(4):622-30. PubMed ID: 8617995
[TBL] [Abstract][Full Text] [Related]
30. Cloning of the mink plasminogen activator inhibitor type-1 messenger RNA: an mRNA with a short half life.
Chuang TH; Hamilton RT; Nilsen-Hamilton M
Gene; 1995 Sep; 162(2):303-8. PubMed ID: 7557448
[TBL] [Abstract][Full Text] [Related]
31. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate.
Lohi J; Lehti K; Westermarck J; Kähäri VM; Keski-Oja J
Eur J Biochem; 1996 Jul; 239(2):239-47. PubMed ID: 8706726
[TBL] [Abstract][Full Text] [Related]
32. Multiple instability-regulating sites in the 3' untranslated region of the urokinase-type plasminogen activator mRNA.
Nanbu R; Menoud PA; Nagamine Y
Mol Cell Biol; 1994 Jul; 14(7):4920-8. PubMed ID: 8007988
[TBL] [Abstract][Full Text] [Related]
33. On the regulation of the plasminogen activator inhibitor-1 gene expression.
Descheemaeker K
Verh K Acad Geneeskd Belg; 1993; 55(3):225-64. PubMed ID: 8342330
[TBL] [Abstract][Full Text] [Related]
34. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
[TBL] [Abstract][Full Text] [Related]
35. Regulation of intercellular adhesion molecule-1 gene expression involves multiple mRNA stabilization mechanisms: effects of interferon-gamma and phorbol myristate acetate.
Ohh M; Smith CA; Carpenito C; Takei F
Blood; 1994 Oct; 84(8):2632-9. PubMed ID: 7919377
[TBL] [Abstract][Full Text] [Related]
36. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated.
Hsu HY; Nicholson AC; Hajjar DP
J Biol Chem; 1996 Mar; 271(13):7767-73. PubMed ID: 8631819
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the human plasminogen activator inhibitor type 2 gene: cooperation of an upstream silencer and transactivator.
Stringer B; Udofa EA; Antalis TM
J Biol Chem; 2012 Mar; 287(13):10579-10589. PubMed ID: 22334683
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-alpha regulates plasminogen activator inhibitor-1 in rat testicular peritubular cells.
Le Magueresse-Battistoni B; Pernod G; Kolodié L; Morera AM; Benahmed M
Endocrinology; 1997 Mar; 138(3):1097-105. PubMed ID: 9048615
[TBL] [Abstract][Full Text] [Related]
40. Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.
Thalacker FW; Nilsen-Hamilton M
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):855-62. PubMed ID: 1332686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
